1,366
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study

, , , , , , , & show all
Pages 150-158 | Received 06 Feb 2019, Accepted 16 Sep 2019, Published online: 09 Oct 2019

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Kaprin A, Starinsky V, Petrov G. Malignant neoplasms in Russia in 2016 (Morbidity and Mortality). Moscow, Russia: P. A. Hertsen Moscow Oncology Research Center - Branch of FSBI NMRRC of the Ministry of Health of Russia; 2018.
  • Kaprin A, Starinsky V, Petrov G. Status of oncological assistance to the population of Russia in 2016. Moscow, Russia: P. A. Hertsen Moscow Oncology Research Center - Branch of FSBI NMRRC of the Ministry of Health of Russia; 2017.
  • Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(Suppl_5):v38–v49.
  • Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20(4):633–649.
  • World Cancer Research Fund International. Continuous Update Project: Diet, nutrition, physical activity and stomach cancer 2016. [cited 2018 26 Mar]. Available from: https://wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf
  • Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet. 2016;388(10060):2654–2664.
  • Wagner AD, Syn NL, Moehler M, et al. Chemotherapy for advanced gastric cancer. Cochrane Db Syst Rev. 2017;8:Cd004064.
  • Bilici A. Treatment options in patients with metastatic gastric cancer: current status and future perspectives. WJG.. 2014;20(14):3905–3915.
  • Hecht JR, Bang YJ, Qin SK, et al. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC–A Randomized Phase III Trial. JCO. 2016;34(5):443–451.
  • Lordick F, Kang YK, Chung HC, et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14(6):490–499.
  • Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–1079. discussion 1081-90.
  • Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
  • Shen L, Shan YS, Hu HM, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–47.
  • Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19(7):689–701.
  • Rota M, Pelucchi C, Bertuccio P, et al. Alcohol consumption and gastric cancer risk-A pooled analysis within the StoP project consortium. Int J Cancer. 2017;141(10):1950–1962.
  • Zaridze D, Borisova E, Maximovitch D, et al. Alcohol consumption, smoking and risk of gastric cancer: case-control study from Moscow, Russia. Cancer Causes Control. 2000;11(4):363–371.
  • Ter-Ovanesov M, Yalcin S, Zalcberg J, et al. Registry of gastric cancer treatment evaluation (REGATE): II treatment practice. Asia-Pac J Clin Oncol. 2013;9(4):373–380.
  • Ajani JA, D'Amico TA, Almhanna K, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Ne. 2016;14(10):1286–1312.
  • Carter GC, Kaltenboeck A, Ivanova J, et al. Real-world treatment patterns among patients with advanced gastric cancer in South Korea. Cancer Res Treat. 2017;49(3):578–587.
  • Cuyun Carter G, Kaltenboeck A, Ivanova J, et al. Treatment patterns in patients with advanced gastric cancer in Taiwan. Asia-Pac J Clin Oncol. 2017;13(3):185–194.
  • Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–209.
  • Kim ST, Cristescu R, Bass AJ, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449–1458.
  • Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–413.
  • Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol. 2014;15(5):489–538.
  • Levi F, Lucchini F, Gonzalez JR, et al. Monitoring falls in gastric cancer mortality in Europe. Ann Onco. 2004;15(2):338–345. Feb
  • Primic-Zakelj M, Zadnik V, Zagar T. Is cancer epidemiology different in Western Europe to that in Eastern Europe? Ann Onco. 2005;16(Suppl 2):ii27–9.